Skip to main
TRUP

Trupanion (TRUP) Stock Forecast & Price Target

Trupanion (TRUP) Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 25%
Buy 25%
Hold 50%
Sell 0%
Strong Sell 0%

Bulls say

Trupanion is a leading provider of medical insurance plans for cats and dogs, with a strong presence in the United States and Canada. The company's unique ability to accurately price risk and its focus on passing on value to consumers through higher claims payout ratios make it well-positioned for growth in the underpenetrated pet insurance market. Additionally, Trupanion's structural cost advantages allow for a sustainable business model and potential for strong financial performance.

Bears say

Trupanion is facing declining market share, decelerating IRR, and limited growth potential due to its failure to implement broader-reaching plans. Risks to its rating and target price include incorrect assumptions on customer lifetime value, competition, regulatory compliance, claims exceeding reserves, and a lack of comparable publicly traded pet insurance companies. While the company beat earnings and revenue estimates, there is concern about decelerating revenue growth and the potential impact of AI on its business.

Trupanion (TRUP) has been analyzed by 4 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 25% recommend Buy, 50% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Trupanion and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Trupanion (TRUP) Forecast

Analysts have given Trupanion (TRUP) a Buy based on their latest research and market trends.

According to 4 analysts, Trupanion (TRUP) has a Buy consensus rating as of May 12, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $42.25, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $42.25, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Trupanion (TRUP)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.